Search Results
Found 1 results
510(k) Data Aggregation
(30 days)
1417WCE, 1417WCE-HR, 1417WCE-HS, 1417WCE-GF
Digital Flat Panel X-Ray Detector is indicated for digital imaging solution designed for general radiographic system for human anatomy. It is intended to replace film or screen based radiographic systems in all general purpose diagnostic procedures. Not to be used for mammography.
1417WCE, 1417WCE-HR, 1417WCE-HS, 1417WCE-GF X-ray detectors, are wired/wireless digital solid state X-ray detectors that are based on flat panel technology. The wireless LAN (IEEE 802.11 n/ac) communication signals images captured to the system and improves the user operability through high speed processing. These radiographic image detectors are processing unit consist of a scintillator coupled to an a-Si TFT sensor. These devices need to be integrated with a static radiographic imaging system. It can be utilized to capture and digitalize X-ray images for radiographic diagnosis.
The revised 510k Summary specified that 1417WCE, 1417WCE-HR, 1417WCE-HS, 1417WCE-GF includes the software (firmware) of MODERATE level of concern. It's the same Image Acquisition and Operating Software used for the predictive device is used but modified to include additional detector models in comparison with the predicate device.
The RAW files can be further processed as DICOM compatible image files by separate consol SW (K190866, XmaruView V1 / Rayence Co.,Ltd) for a radiographic diagnosis and analysis. The imaging software XMaru View V1 is not part of the subject device.
1417WCE is the basic model. 1417WCE-HR is identical with the basic model except for the pixel pitch size. 417WCE-HS is identical with the basic model except for the case color. 1417WCE-GF is identical with the basic model except for the case color and the pixel pitch size. The differences are not safety related.
The provided text is a 510(k) summary for Rayence Co., Ltd.'s X-ray detectors (1417WCE, 1417WCE-HR, 1417WCE-HS, 1417WCE-GF). It describes the substantial equivalence of these new devices to a previously cleared predicate device (1417WCC, K171418), rather than proving the device meets a specific set of new clinical acceptance criteria through a clinical study.
The core of this submission is non-clinical performance testing to demonstrate that the new devices perform equivalently or better than the predicate, not a clinical study proving diagnostic accuracy or human performance improvement.
Therefore, many of the requested elements for a clinical study (like sample size for test sets, data provenance, number of experts, adjudication methods, MRMC studies, standalone performance with ground truth methods, and training set details) are not applicable or not explicitly stated in this type of submission.
However, I can extract information related to the acceptance criteria implicitly used for substantial equivalence and the non-clinical study details that support the performance claims.
Here's an analysis based on the provided document:
Acceptance Criteria and Reported Device Performance (Implicit for Substantial Equivalence)
The acceptance criteria for this 510(k) submission are implicitly tied to demonstrating substantial equivalence to the predicate device (1417WCC). This means showing that the new devices are as safe and effective as the predicate. The "performance" in this context refers to technical imaging characteristics rather than diagnostic accuracy in a clinical setting.
Implicit Acceptance Criteria and Reported Device Performance:
Acceptance Criteria (Implicit for Substantial Equivalence) | Reported Device Performance (New Devices vs. Predicate) |
---|---|
Identical Indications for Use | Met: All new models have identical Indications for Use as the predicate: "Digital Flat Panel X-Ray Detector is indicated for digital imaging solution designed for general radiographic system for human anatomy. It is intended to replace film or screen based radiographic systems in all general purpose diagnostic procedures. Not to be used for mammography." |
Similar Technological Characteristics: | |
- Detector Type | Met: All new models use Amorphous Silicon, TFT, same as predicate. |
- Scintillator | Met: All new models use CsI:Tl, same as predicate. |
- Imaging Area | Met: All new models have 14 x 17 inches, same as predicate. |
- Pixel Matrix / Pixel Pitch | Similar: New models offer 100μm and 140μm pixel pitches (3534x4302 and 2500x3052 pixel matrices). Predicate had 127μm and 140μm (3328x2816 and 2500x3052). Differences "do not raise new concerns for safety and effectiveness." |
- Resolution | Similar: New models show 5.00 lp/mm (100μm) and 3.57 lp/mm (140μm). Predicate had 3.93 lp/mm (127μm) and 3.57 lp/mm (140μm). Generally comparable or improved. |
- DQE (@1lp/mm) | Similar/Better: New models: Typ. 62% (100μm), 63% (140μm). Predicate: Typ. 59% (127μm), 61% (140μm). The new models show slightly higher DQE. |
- MTF (@1lp/mm) | Similar/Better: New models: Typ. 60% (100μm), 66% (140μm). Predicate: Typ. 55% (127μm), 53% (140μm). The new models show higher MTF. |
- A/D Conversion | Similar: New models use 16 bits. Predicate used 14/16 bits. |
- Dimensions & Weight | Similar: Comparable dimensions and weight. |
Equivalent or Better Image Quality (Qualitative Review) | Met: "After comparing a broad review of plain radiographic images taken with 1417WCE, 1417WCE-HR, 1417WCE-HS, 1417WCE-GF and 1417WCC images obtained equivalent quality for the same view obtained from a similar patient." |
Sufficient Image Quality for Diagnostic Purposes | Met: "both 1417 WCE 140 um and 1417 WCE 100 um have demonstrated sufficient image quality which will provide aid for diagnostic purposes." (Specifically, 100um showed "sharper cortical lines," and 140um showed "sharper cortical lines and trabecular patterns with less image noise and overall better contrast.") |
Conformance to Relevant Standards | Met: Non-clinical tests performed according to IEC 62220-1. Electrical, mechanical and environmental safety testing according to IEC 60601-1, EMC testing to IEC 60601-1-2. |
Risk Mitigation | Met: FMEA method used for risk analysis. "overall assessment concluded that all risks and hazardous conditions identified arising from the design change were successfully mitigated and accepted." |
Study Details (Non-Clinical Performance Testing for Substantial Equivalence)
The provided document describes non-clinical performance testing and a qualitative image review to support substantial equivalence, rather than a full-scale clinical trial with human subjects and diagnostic outcomes.
-
Sample size used for the test set and the data provenance:
- Test Set Sample Size: Not specified in terms of number of images or patients for the qualitative review. The document mentions comparing "plain radiographic images" from the new devices and the predicate.
- Data Provenance: Not explicitly stated (e.g., country of origin). The comparison indicates the images were "taken with" the devices and from "a similar patient," implying they were internally generated or acquired for comparison. It was a retrospective comparison of existing image types (though not necessarily existing patient data in a large dataset).
-
Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
- Not Applicable in the traditional sense of diagnostic ground truth. For the qualitative image review, the document states: "After comparing a broad review of plain radiographic images... images obtained equivalent quality..." This implies a subjective assessment, likely by internal experts, but the number and qualifications are not specified. This is a technical comparison for substantial equivalence, not a diagnostic accuracy study requiring independent expert ground truth for clinical endpoints.
-
Adjudication method (e.g. 2+1, 3+1, none) for the test set:
- None described. The qualitative image review mentions a "broad review," implying an assessment was made, but no formal adjudication process (like 2+1 reader agreement) is detailed.
-
If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No, an MRMC comparative effectiveness study was NOT done. This submission is for digital X-ray detectors themselves, not an AI-powered diagnostic assistance tool. Therefore, a study on human reader improvement with AI assistance is not applicable.
-
If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:
- Yes, in the sense of technical performance testing. The device's technical performance (MTF, DQE, NPS) was evaluated "algorithm only" (as in, device output without human interpretation in the loop) and compared to the predicate device, following international standards (IEC 62220-1). However, this is not a "standalone performance" study measuring diagnostic accuracy.
-
The type of ground truth used (expert consensus, pathology, outcomes data, etc):
- Primarily
technical specifications and qualitative comparison; no traditional diagnostic ground truth. The "ground truth" for this submission are the measured physical properties of the detectors (e.g., MTF, DQE values determined by standardized phantoms) and the subjective assessment of image quality against the predicate. This is sufficient for demonstrating substantial equivalence for a medical imaging device (detector), not for an AI algorithm that provides a diagnostic output.
- Primarily
-
The sample size for the training set:
- Not Applicable. This submission is for a physical X-ray detector, not an AI or machine learning algorithm that requires a "training set."
-
How the ground truth for the training set was established:
- Not Applicable. As there is no training set for this device type, no ground truth needed to be established for it.
Ask a specific question about this device
Page 1 of 1